Löning T - Search Results

1

Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

Müller V, Witzel I, Lück HJ, Köhler G, von Minckwitz G, Möbus V, Sattler D, Wilczak W, Löning T, Jänicke F, Pantel K, Thomssen C. Müller V, et al. Among authors: loning t. Breast Cancer Res Treat. 2004 Jul;86(1):9-18. doi: 10.1023/B:BREA.0000032919.83803.48. Breast Cancer Res Treat. 2004. PMID: 15218357 Clinical Trial.

2

Quantitative assessment of HER-2/neu protein concentration in breast cancer by enzyme-linked immunosorbent assay.

Müller V, Thomssen C, Karakas C, Eustermann I, Ramirez Porras J, Coith C, Berger J, Löning T, Jänicke F, Pantel K. Müller V, et al. Among authors: loning t. Int J Biol Markers. 2003 Jan-Mar;18(1):13-20. doi: 10.1177/172460080301800103. Int J Biol Markers. 2003. PMID: 12699058 Free article.

3

Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.

Milde-Langosch K, Janke S, Wagner I, Schröder C, Streichert T, Bamberger AM, Jänicke F, Löning T. Milde-Langosch K, et al. Among authors: loning t. Breast Cancer Res Treat. 2008 Feb;107(3):337-47. doi: 10.1007/s10549-007-9559-y. Epub 2007 Mar 28. Breast Cancer Res Treat. 2008. PMID: 17393299

4

Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.

Knippen S, Löning T, Müller V, Schröder C, Jänicke F, Milde-Langosch K. Knippen S, et al. Among authors: loning t. Anticancer Res. 2009 Jan;29(1):183-9. Anticancer Res. 2009. PMID: 19331149 Free article.

5

MAGE-A gene expression pattern in primary breast cancer.

Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Löning T, Jänicke F, Pantel K. Otte M, et al. Among authors: loning t. Cancer Res. 2001 Sep 15;61(18):6682-7. Cancer Res. 2001. PMID: 11559535

6

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer.

Milde-Langosch K, Bamberger AM, Rieck G, Grund D, Hemminger G, Müller V, Löning T. Milde-Langosch K, et al. Among authors: loning t. Br J Cancer. 2005 Jun 20;92(12):2206-15. doi: 10.1038/sj.bjc.6602655. Br J Cancer. 2005. PMID: 15928662 Free PMC article.

7

Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.

Woelfle U, Breit E, Zafrakas K, Otte M, Schubert F, Müller V, Izbicki JR, Löning T, Pantel K. Woelfle U, et al. Among authors: loning t. J Immunol Methods. 2005 May;300(1-2):136-45. doi: 10.1016/j.jim.2005.03.006. Epub 2005 Apr 18. J Immunol Methods. 2005. PMID: 15907331

8

Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin.

Ihnen M, Kilic E, Köhler N, Löning T, Witzel I, Hagel C, Höller S, Kersten JF, Müller V, Jänicke F, Milde-Langosch K. Ihnen M, et al. Among authors: loning t. J Clin Pathol. 2011 Feb;64(2):146-52. doi: 10.1136/jcp.2010.082602. J Clin Pathol. 2011. PMID: 21262777

9

[Algorithm of clinical aspects and pathology of endometrial carcinoma].

Löning T, Reusch U, Thomssen C. Löning T, et al. Pathologe. 1999 Jan;20(1):63-71. doi: 10.1007/s002920050321. Pathologe. 1999. PMID: 10091234 German.

10

Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.

Kröger N, Milde-Langosch K, Riethdorf S, Schmoor C, Schumacher M, Zander AR, Löning T. Kröger N, et al. Among authors: loning t. Clin Cancer Res. 2006 Jan 1;12(1):159-68. doi: 10.1158/1078-0432.CCR-05-1340. Clin Cancer Res. 2006. PMID: 16397038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page